Tae-Dong Han

Title: Innovations and Contributions of Inventor Tae-Dong Han

Introduction

Tae-Dong Han is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, his work focuses on compounds that have the potential to treat various diseases.

Latest Patents

One of his latest patents involves derivatives having a 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salts thereof. This invention provides a compound that exhibits inhibitory activity against glucosylceramide synthase (GCS), making it applicable for preventing or treating diseases such as Gaucher disease, Fabry disease, Tay-Sachs disease, and Parkinson's disease. Another significant patent is a quinazoline derivative or its salt, which has selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit. This compound can be used for cancer treatment while minimizing side effects like lymphopenia-associated inflammatory responses.

Career Highlights

Tae-Dong Han has worked with prominent companies in the pharmaceutical industry, including Yuhan Corporation and The Green Cross Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, he has collaborated with notable colleagues such as Dong-Hoon Kim and Eui-Chul Lee. These partnerships have likely enhanced his research and development efforts.

Conclusion

Tae-Dong Han's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex diseases and the potential for new treatments.